Both in Pharmaceuticals
Arvinas vs Ovid Therapeutics
Over the past year ARVN returned −12.1% and OVID returned +81.4%; their daily moves had a correlation of 0.33.
ARVN −12.1% OVID +81.4%Growth of $1, one year, split-adjusted
| Metric | ARVN | OVID |
|---|---|---|
| Price | $7.50 | $2.54 |
| Market cap | $490.4M | $496.1M |
| Today | −0.13% | +3.25% |
| 1 month | −18.3% | −9.3% |
| 6 months | −26.3% | +20.4% |
| Year to date | −36.8% | +55.8% |
| 1 year | −9.3% | +46.8% |
| Revenue growth (YoY) | +1014.7% | −88.3% |
| Gross margin | 96.4% | 100.0% |
| Net margin | 67.8% | −2047.6% |
| P/E (TTM) | 52.7× | — |
| Price / sales | 1.5× | 313.4× |
| Net cash | $567.6M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 46.1% | 51.8% |
| Short % of float | 9.1% | 13.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).